EPtalk by Dr. Jayne 3/5/26

Why It Matters

EHR platform choices affect data exchange, patient experience, and market competition, while DTC testing reshapes how consumers access health services.

Key Takeaways

• Rehoboth McKinley not using Epic EHR
• Great Falls Clinic also lacks Epic implementation
• Rehoboth McKinley uses Cerner/Oracle portal
• LinkedIn post highlights EHR market fragmentation
• DTC testing debate resurfaces on LinkedIn

Pulse Analysis

The health‑information technology landscape remains fragmented, as evidenced by Wayne Gillis’s LinkedIn observation that two mid‑size providers—Rehoboth McKinley and Great Falls Clinic—have not adopted Epic’s dominant EHR system. Instead, Rehoboth McKinley relies on a Cerner/Oracle patient portal, illustrating how regional health networks continue to mix platforms based on legacy contracts, cost considerations, and specific workflow needs. This patchwork of systems hampers seamless data exchange, forcing clinicians to navigate multiple interfaces and potentially delaying critical patient information.

Concurrently, the conversation around direct‑to‑consumer (DTC) laboratory testing has gained renewed momentum on professional networks. Stakeholders are debating the regulatory, ethical, and clinical implications of allowing patients to order tests without a physician’s order, a model distinct from Direct Access Testing (DAT) where clinicians facilitate patient‑initiated testing. Proponents argue DTC empowers patients and accelerates preventive care, while critics warn of misinterpretation of results and increased downstream costs. The LinkedIn thread linking to a New Yorker cartoon and industry articles underscores the cultural and professional curiosity surrounding this shift.

Both EHR heterogeneity and the rise of DTC testing signal a broader transformation in how healthcare data is captured, shared, and acted upon. Organizations must balance the agility of adopting newer platforms with the responsibility of maintaining interoperability standards. Meanwhile, regulators and payers are watching DTC trends closely, preparing policies that protect patients without stifling innovation. For providers, understanding these dynamics is essential to stay competitive, improve patient outcomes, and navigate the evolving digital health ecosystem.